Latest filing published 08 Apr 2024 for NGM Biopharmaceuticals INC.
Insider track record
No signal scores available.
TCG Opportunity III GP, LLC: trading record in brief
TCG Opportunity III GP, LLC is a declared insider of NGM Biopharmaceuticals Inc, with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 5 April 2024, with 14 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 8 April 2024, the filings show a transaction in NGM Biopharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to TCG Opportunity III GP, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,650,177 sharesCommon StockSEC:0000950142-24-001002:1
- 90,442 sharesCommon StockSEC:0000950142-24-001002:2
- 11,103,333 sharesCommon StockSEC:0000950142-24-001002:3
- 858,035 sharesCommon StockSEC:0000950142-24-001002:4
- 968,990 sharesCommon StockSEC:0000950142-24-001002:5
- 2,265,758 sharesCommon StockSEC:0000950142-24-001002:6
- 1,298,908 sharesCommon StockSEC:0000950142-24-001002:7
- 1,298,908 sharesCommon StockSEC:0000950142-24-001002:8
- 100,000 sharesCommon StockSEC:0000950142-24-001002:9
- 100,000 sharesCommon StockSEC:0000950142-24-001002:10
- 15,000 sharesCommon StockSEC:0000950142-24-001002:11
- 44,000 sharesCommon StockSEC:0000950142-24-001002:12
- 1,000 sharesCommon StockSEC:0000950142-24-001002:13
- 949,862 sharesCommon StockSEC:0000950142-24-001002:0
14 of 14 declarations